A Review on Newly Invented Drug Rapiblyk: Used for treatment of Supraventricular Tachycardia

December 2024
Vol-10, Issue-6
Paper ID: 25428
ISSN: 2395-4396
Downloads: 0

Abstract & Details

Research Area
Pharmacy
Keywords
Rapiblyk Landiolol Supraventricular Tachycardia Lower the Ventricular Rate
Abstract
Rapiblyk it may contain landiolol is mainly prescribed for the treatmnent for short-term management of supraventricular tachycardia that are including atrial fibrillation and atrial flutter to lowers the ventricular rate. Rapiblyk is approved by 22November 2024 by FDA. They are available dosage form in the Lyophilized powder for injection use and manufacture is AOP Orphan Pharmaceuticals GmbH. Rapiblyk molecular formula is C25H39N3O8 and Molecular weight is 509.6 g/mol. The most frequently reported side effect of Rapiblyk is low blood pressure. Rapiblyk drug get contain Active Ingredient is Landiolol and Inactive Ingredients is Mannitol and sodium hydroxide used for pH adjustment. Keep unreconstituted or new vials stored at a temperature of 20°C to 25°C.
License
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.

Author Information

# Name Institute / Affiliation
1 Mr. Shubham B Mandhare Sanjivani College of Pharmaceutical Education and Research Kopargaon

How to Cite

Use the following formats to cite this article in your research.

APA Style
Mandhare, Mr. Shubham B (2024). A Review on Newly Invented Drug Rapiblyk: Used for treatment of Supraventricular Tachycardia. International Journal of Advance Research and Innovative Ideas In Education, 10(6), 1261-1265.
MLA Style
Mandhare, Mr. Shubham B. "A Review on Newly Invented Drug Rapiblyk: Used for treatment of Supraventricular Tachycardia." International Journal of Advance Research and Innovative Ideas In Education, vol. 10, no. 6, 2024, pp. 1261-1265.
IEEE Style
Mr. Shubham B Mandhare, "A Review on Newly Invented Drug Rapiblyk: Used for treatment of Supraventricular Tachycardia," International Journal of Advance Research and Innovative Ideas In Education, vol. 10, no. 6, pp. 1261-1265, 2024.
Vancouver Style
Mandhare Mr. Shubham B. A Review on Newly Invented Drug Rapiblyk: Used for treatment of Supraventricular Tachycardia. International Journal of Advance Research and Innovative Ideas In Education. 2024;10(6):1261-1265.
Harvard Style
Mandhare, Mr. Shubham B (2024) 'A Review on Newly Invented Drug Rapiblyk: Used for treatment of Supraventricular Tachycardia', International Journal of Advance Research and Innovative Ideas In Education, 10(6), pp. 1261-1265.
Chicago Style
Mandhare, Mr. Shubham B. "A Review on Newly Invented Drug Rapiblyk: Used for treatment of Supraventricular Tachycardia." International Journal of Advance Research and Innovative Ideas In Education 10, no. 6 (2024): 1261-1265.
Turabian Style
Mandhare, Mr. Shubham B. "A Review on Newly Invented Drug Rapiblyk: Used for treatment of Supraventricular Tachycardia." International Journal of Advance Research and Innovative Ideas In Education 10, no. 6 (2024): 1261-1265.

Export Citation